Brief: Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
17/04/2024 14:21
April 17 (Reuters) - Hyperfine Inc HYPR.O :
* LEADING INSTITUTIONS ENROLL FIRST ALZHEIMER’S PATIENTS
RECEIVING
AMYLOID-TARGETING THERAPY IN CARE PMR STUDY
Source text for Eikon: ID:nBw2cDpxqa
Further company coverage: HYPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hyperfine
See all newsPortable MRI maker Hyperfine's Q3 prelim revenue beats estimates; FY outlook reaffirmed
Brief: Hyperfine, Inc. Q3 Sales USD 6 Million
Hyperfine Inc reports results for the quarter ended June 30 - Earnings Summary
Portable MRI maker Hyperfine's Q2 revenue rises less than expected
Brief: Hyperfine, Inc. Q2 EPS USD -0.09